HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qun Li Selected Research

A 289099

3/2003Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivative.
2/2002Synthesis and biological evaluation of 2-indolyloxazolines as a new class of tubulin polymerization inhibitors. Discovery of A-289099 as an orally active antitumor agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qun Li Research Topics

Disease

96Neoplasms (Cancer)
09/2022 - 02/2002
21Squamous Cell Carcinoma of Head and Neck
07/2022 - 05/2009
19Infections
01/2020 - 10/2007
17Esophageal Squamous Cell Carcinoma
12/2021 - 01/2013
14Neoplasm Metastasis (Metastasis)
09/2022 - 02/2011
13Breast Neoplasms (Breast Cancer)
01/2022 - 02/2011
9Carcinogenesis
01/2022 - 07/2005
9Inflammation (Inflammations)
01/2021 - 06/2007
7Glioma (Gliomas)
01/2022 - 01/2015
7Hypertension (High Blood Pressure)
10/2021 - 09/2003
7Prolactinoma (Prolactinomas)
01/2021 - 01/2017
7Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 12/2008
7Disease Resistance
10/2019 - 02/2004
7AIDS-Related Complex (ARC)
11/2016 - 12/2007
6Pain (Aches)
01/2022 - 07/2007
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 11/2004
5Carcinoma (Carcinomatosis)
01/2022 - 07/2005
5Stroke (Strokes)
09/2020 - 06/2003
5Spinal Cord Injuries (Spinal Cord Injury)
09/2019 - 10/2003
5Sepsis (Septicemia)
07/2018 - 07/2008
5Tuberculosis (Tuberculoses)
07/2018 - 06/2005
4Fibrosis (Cirrhosis)
06/2022 - 01/2006
4Liver Neoplasms (Liver Cancer)
01/2022 - 04/2021
4Disease Progression
01/2022 - 01/2019
4Hemorrhage
01/2022 - 11/2008
4Lymphatic Metastasis
12/2021 - 02/2015
4Hepatocellular Carcinoma (Hepatoma)
12/2021 - 10/2016
4Brain Injuries (Brain Injury)
11/2021 - 02/2008
4Pneumonia (Pneumonitis)
01/2020 - 11/2007
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 02/2011
4Papillary Thyroid Cancer
01/2020 - 06/2014
4Obesity
12/2019 - 09/2007
4Diabetes Mellitus
11/2019 - 07/2004
4Body Weight (Weight, Body)
01/2016 - 01/2014
4Hyperglycemia
03/2014 - 01/2006
4Glucose Intolerance
09/2013 - 11/2006
3COVID-19
01/2022 - 09/2020
3Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 04/2011
3Hypersensitivity (Allergy)
01/2021 - 03/2007
3Pituitary Neoplasms (Pituitary Adenoma)
01/2021 - 12/2012
3Glioblastoma (Glioblastoma Multiforme)
01/2021 - 06/2020
3ST Elevation Myocardial Infarction
01/2021 - 01/2015
3Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2021 - 12/2019
3Triple Negative Breast Neoplasms
12/2020 - 12/2017
3Fever (Fevers)
12/2020 - 06/2003
3Adenocarcinoma
11/2020 - 11/2004
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2019
3Weight Loss (Weight Reduction)
10/2019 - 06/2005
3Neuralgia (Stump Neuralgia)
10/2019 - 01/2013
3Human Influenza (Influenza)
01/2017 - 01/2009

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
09/2022 - 05/2007
22Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2011
17Long Noncoding RNAIBA
06/2022 - 01/2014
14Messenger RNA (mRNA)IBA
01/2022 - 03/2011
13Pharmaceutical PreparationsIBA
03/2022 - 03/2003
10RNA (Ribonucleic Acid)IBA
01/2022 - 08/2009
9Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2005
8Biological ProductsIBA
01/2022 - 03/2006
8MicroRNAs (MicroRNA)IBA
01/2022 - 12/2017
8CytokinesIBA
08/2018 - 06/2007
7AntibodiesIBA
12/2019 - 05/2008
5Therapeutic UsesIBA
01/2022 - 11/2005
5Dopamine Agonists (Dopamine Agonist)IBA
01/2021 - 04/2017
5DNA (Deoxyribonucleic Acid)IBA
01/2019 - 11/2008
5Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2007 - 09/2002
4Estrogen ReceptorsIBA
01/2022 - 10/2012
4Circular RNAIBA
01/2022 - 12/2021
4LigandsIBA
01/2021 - 02/2011
4Alanine Transaminase (SGPT)IBA
12/2020 - 04/2009
4Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 10/2004
4Streptozocin (Streptozotocin)FDA Link
07/2014 - 07/2004
3EnzymesIBA
09/2022 - 02/2006
3Immune Checkpoint InhibitorsIBA
06/2022 - 01/2019
3CabergolineFDA LinkGeneric
01/2021 - 09/2018
3Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 12/2019
3amsonic acid (DAS)IBA
01/2021 - 04/2017
3Small Interfering RNA (siRNA)IBA
01/2021 - 01/2016
3Nucleic AcidsIBA
12/2020 - 11/2007
3ORALIT (ORS)IBA
10/2019 - 01/2013
3Doxorubicin (Adriamycin)FDA LinkGeneric
09/2019 - 05/2008
3Sirtuin 1IBA
03/2019 - 01/2018
3Phosphotransferases (Kinase)IBA
01/2018 - 09/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018 - 03/2008
3Caspase 3 (Caspase-3)IBA
01/2016 - 08/2011
3SteroidsIBA
01/2016 - 06/2008
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2015 - 10/2003
3KisspeptinsIBA
01/2015 - 05/2010

Therapy/Procedure

34Therapeutics
09/2022 - 11/2004
21Radiotherapy
01/2022 - 04/2004
18Drug Therapy (Chemotherapy)
06/2022 - 09/2002
9Chemoradiotherapy
01/2021 - 12/2008
8Neoadjuvant Therapy
12/2021 - 12/2008
5Immunotherapy
07/2022 - 01/2009
5Transplantation
07/2020 - 10/2006
4Lymph Node Excision (Lymph Node Dissection)
02/2021 - 02/2003
4Aftercare (After-Treatment)
01/2021 - 03/2003
4Esophagectomy
11/2015 - 01/2013
3Percutaneous Coronary Intervention
01/2021 - 01/2015
3Ligation
07/2017 - 02/2008
3Mastectomy (Mammectomy)
10/2015 - 10/2012